5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN6682 | Cyclo(Phe-Gly) | ||
Cyclo(Phe-Gly) shows weak antagonistic activity against VEGFR2 -CD, it also shows strong inhibitory activity against human cancer cells(KB,KBv200) with LD50 at 6.5 and 11.2 umol/L,respectively. | |||
T10920 | Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA | Others | |
Arg-Gly-Asp-D-Phe-Val (TFA) has anti-tumor activity and is an inhibitor of integrin αvβ3. | |||
T82643 | cyclo(Phe-Ala-Gly-Arg-Arg-Arg-Gly-AEEAc) | ||
Cyclo(Phe-Ala-Gly-Arg-Arg-Arg-Gly-AEEAc) is a potential nonhormonal male contraceptive that functions through the inhibition of GRTH/DDX25 phosphorylation. | |||
T75990 | Cyclo(Arg-Gly-Asp-D-Phe-Val) | ||
Cyclo(Arg-Gly-Asp-D-Phe-Val) is an integrin αvβ3 inhibitor with antitumor properties, utilized in the research of acute myeloid leukemia [1]. | |||
T76068 | Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA | ||
Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA (Cyclo RGDfC) TFA, a cyclic RGD peptide, displays a high affinity for αvβ3 integrin, effectively disrupting cell-integrin interactions. It suppresses pluripotent marker expression in embr... |